Related Experiment Video

Updated: Apr 25, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

9.0K

Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome

Austin G Kulasekararaj1, Jie Jiang1, Alexander E Smith1

  • 1Department of Haematological Medicine, King's College London School of Medicine, London, United Kingdom; and Department of Haematology, King's College Hospital, London, United Kingdom.

Blood
|August 21, 2014
PubMed

Insights

Somatic mutations are found in 19% of acquired aplastic anemia (AA) patients, predicting transformation to myelodysplastic syndromes (MDS). These mutations indicate a higher risk of progression in AA patients with longer disease duration.

Area of Science:

  • Hematology
  • Oncology
  • Genetics

Background:

  • Distinguishing acquired aplastic anemia (AA) from hypocellular myelodysplastic syndrome (hMDS) is challenging, particularly in non-severe cases.
  • Somatic mutations may be present in a subset of AA patients and could predict disease progression.

Purpose of the Study:

  • To investigate the presence and significance of somatic mutations in acquired aplastic anemia patients.
  • To determine if somatic mutations predict malignant transformation to myelodysplastic syndromes.

Main Methods:

  • Somatic mutation screening of 835 genes in 57 AA patients and targeted sequencing of 5 genes (ASXL1, DNMT3A, BCOR, TET2, MPL) in 93 AA patients.
  • Exclusion of Fanconi anemia, telomere maintenance mutations, and family history of bone marrow failure or cancer.
  • Analysis of mutation presence, disease duration, telomere length, and transformation risk to myelodysplastic syndromes.

Main Results:

  • Somatic mutations were detected in 19% of acquired aplastic anemia patients, including ASXL1, DNMT3A, and BCOR.
  • Patients with somatic mutations exhibited longer disease duration and shorter telomere lengths compared to those without mutations.
  • Somatic mutations in AA patients with disease duration >6 months were associated with a 40% risk of transformation to myelodysplastic syndromes.

Conclusions:

  • A significant proportion of acquired aplastic anemia patients harbor mutations typically found in myeloid malignancies.
  • Somatic mutations serve as a predictive marker for the transformation of acquired aplastic anemia to myelodysplastic syndromes.

More Related Videos

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

2.0K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

26.0K

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.0K
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
5.4K